Matthias Schiemann Selected Research

Matthias Schiemann Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 08/2005
9	Infections 12/2021 - 05/2004
2	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2013
2	Virus Diseases (Viral Diseases) 12/2021 - 02/2007
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 10/2015
2	Atherosclerosis 12/2016 - 08/2007
2	Inflammation (Inflammations) 01/2016 - 04/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Carcinogenesis 01/2023
1	Viremia 01/2019
1	Asthma (Bronchial Asthma) 12/2018
1	Chronic Hepatitis B 01/2017
1	HIV Infections (HIV Infection) 10/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2013
1	Heart Failure 01/2013
1	Infarction (Infarctions) 01/2013
1	Reperfusion Injury 01/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2011
1	Teratoma (Teratoid Tumor) 03/2010
1	Hematologic Neoplasms (Hematological Malignancy) 08/2009
1	Testicular Neoplasms (Testicular Cancer) 08/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007
1	Communicable Diseases (Infectious Diseases) 03/2007
1	Shock 05/2004
1	Septic Shock (Toxic Shock Syndrome) 05/2004

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 10/2021 - 03/2007
4	Peptides (Polypeptides)IBA 10/2015 - 03/2007
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2016
3	EpitopesIBA 01/2019 - 05/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2015 - 08/2009
3	LigandsIBA 04/2007 - 05/2004
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2010
2	CytokinesIBA 01/2017 - 04/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 05/2004
2	Antiviral Agents (Antivirals)IBA 01/2017 - 02/2007
2	Interleukin-2 (IL2)IBA 01/2017 - 10/2016
2	Indicators and Reagents (Reagents)IBA 08/2009 - 03/2007
2	ChemokinesIBA 08/2007 - 04/2005
1	Leucine (L-Leucine)FDA Link 01/2023
1	Differentiation AntigensIBA 01/2023
1	olfactomedinIBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	HLA-A Antigens (HLA-A)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2016
1	Choline (Choline Chloride)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2015
1	GlypicansIBA 10/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2013
1	Tyrosine Kinase InhibitorsIBA 08/2013
1	plerixafor FDA Link 08/2013
1	Small Interfering RNA (siRNA)IBA 08/2013
1	Messenger RNA (mRNA)IBA 08/2013
1	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2013
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	PhosphatidylserinesIBA 01/2013
1	Annexin A5IBA 01/2013
1	Cyclin D1IBA 09/2011
1	RNA (Ribonucleic Acid)IBA 09/2009
1	Cancer VaccinesIBA 08/2009
1	Chemokine CX3CL1IBA 08/2007
1	NK Cell Lectin-Like Receptor Subfamily KIBA 08/2005
1	Interleukin-12 Subunit p40IBA 04/2005
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2005
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 04/2005
1	AutoantibodiesIBA 04/2005
1	Phospholipases (Phospholipase)IBA 04/2005
1	Phospholipase C gammaIBA 04/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2004
1	LipopeptidesIBA 05/2004

Therapy/Procedure

7	Therapeutics 12/2021 - 08/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013